Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INCCOLL · Entity 5169 | See remarks | March 17, 2017 | March 21, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
COLLEGIUM PHARMACEUTICAL, INC
Report date March 17, 2017 · Filed March 21, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 20,087 |
Reported balance
After 2017-03-17 transaction · row 1
1 source rowRow 1 · 2017-03-17 · Tax withholding · Disposed 388 · Balance 20,087 F1: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 17, 2017 Filed Mar 21, 2017 16:43 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | Tax withholdingCommon Stock | 388 | $14.95 | $5,800.60 |
DisclosureSEC source: 0001192482-17-000086 · edgar.xml · nonDerivative · entry 1 Duke Barry S · CIK 0001640699 · See remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,087 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 17:54 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | GrantStock Option (Right to Purchase) · Derivative | 27,500 | $0.00 Strike: $15.27 | $0.00 |
DisclosureSEC source: 0001192482-17-000040 · edgar.xml · derivative · entry 3 Duke Barry S · CIK 0001640699 · See remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,500 Underlying: Common Stock · 27,500 shares Expires 2027-02-10 F3 · derivative.exercise_date: The option vests and becomes exercisable over a four-year period commencing on February 10, 2017. Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2018, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the remaining three years of the four-year period, subject to the employee's continued service with the issuer. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 17:54 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | GrantCommon Stock | 13,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-17-000040 · edgar.xml · nonDerivative · entry 2 Duke Barry S · CIK 0001640699 · See remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,475 F2 · security: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest over a four-year period commencing on February 10, 2017. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2018, and the balance of the restricted stock units vest in equal installments every six months (in each case, rounded up to the nearest whole share of common stock) over the remaining three years of the four-year period, subject to the employee's continued service with the issuer. The restricted stock units will be settled on each applicable vest date in shares of the issuer's common stock. Read SEC document |
| January 27, 2017 Filed Feb 14, 2017 17:54 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | GrantCommon Stock | 834 | $10.08 | $8,406.72 |
DisclosureSEC source: 0001192482-17-000040 · edgar.xml · nonDerivative · entry 1 Duke Barry S · CIK 0001640699 · See remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,725 F1 · kind: These shares were acquired under the Collegium Pharmaceutical, Inc. 2015 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.